0.8101
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 10 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| OncoSec Medical Incorporated | ONCS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.8101 | 04:13:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8101 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 10 | - | 0.80 - 8.1598 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:00:00 | 10 | $ 0.80 | USD |
Period:
Draw Mode:
OncoSec Medical Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 31.86M | 39.33M | 18.97M | $ - | $ - | -1.40 | -0.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -343.00 | 6.80% |
OncoSec Medical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONCS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.02 | 1.115 | 0.80 | 0.9320448 | 374,778 | -0.2099 | -20.58% |
| 1 Month | 1.05 | 1.115 | 0.80 | 0.9222321 | 280,041 | -0.2399 | -22.85% |
| 3 Months | 1.60 | 1.95 | 0.80 | 1.26 | 280,293 | -0.7899 | -49.37% |
| 6 Months | 2.48 | 2.52 | 0.80 | 1.70 | 259,266 | -1.67 | -67.33% |
| 1 Year | 6.18 | 8.1598 | 0.80 | 3.35 | 611,311 | -5.37 | -86.89% |
| 3 Years | 7.15 | 9.50 | 0.80 | 3.71 | 415,856 | -6.34 | -88.67% |
| 5 Years | 12.60 | 29.50 | 0.80 | 10.95 | 659,529 | -11.79 | -93.57% |
OncoSec Medical Description
| OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer. |